|
|
Volumn 351, Issue 6273, 2016, Pages 543-544
|
|
The race for a Zika vaccine is on
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
INACTIVATED VACCINE;
UNCLASSIFIED DRUG;
VIRUS VACCINE;
WEST NILE VACCINE;
ZIKA VACCINE;
BRAIN;
IMMUNE RESPONSE;
PLASMID;
PROTEIN;
PUBLIC HEALTH;
SOUTHERN HEMISPHERE;
TUBERCULOSIS;
VACCINE;
VIRUS;
WORLD HEALTH ORGANIZATION;
CROSS PROTECTION;
DENGUE;
FLAVIVIRUS;
HUMAN;
PRIORITY JOURNAL;
SCIENTIST;
SHORT SURVEY;
VIRUS INFECTION;
ZIKA VIRUS INFECTION;
ECONOMICS;
IMMUNOLOGY;
MARKETING;
MASS IMMUNIZATION;
NATIONAL HEALTH ORGANIZATION;
PREVENTION AND CONTROL;
UNITED STATES;
ZIKA FEVER;
ZIKA VIRUS;
BRAZIL;
GENEVA [SWITZERLAND];
SOUTH AMERICA;
SWITZERLAND;
HUMANS;
MARKETING;
MASS VACCINATION;
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.);
UNITED STATES;
VIRAL VACCINES;
ZIKA VIRUS;
ZIKA VIRUS INFECTION;
|
|
EID: 84957590016
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.351.6273.543 Document Type: Short Survey |
|
Times cited : (25)
|
|
References (0)
|